Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

[Structure, localization and physiologic role of pituitary adenylate cyclase activating polypeptide (PACAP)].

Vincze E, Köves K.

Orv Hetil. 2001 Mar 11;142(10):491-6. Review. Hungarian.

PMID:
11288374
3.

Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.

Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H.

Pharmacol Rev. 2000 Jun;52(2):269-324. Review.

4.
5.

[The discovery of pituitary adenylate cyclase activating polypeptide (PACAP) and its research progress].

Geng L, Ju G.

Sheng Li Ke Xue Jin Zhan. 1997 Jan;28(1):29-34. Review. Chinese.

PMID:
10921074
6.

Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide.

Somogyvári-Vigh A, Reglodi D.

Curr Pharm Des. 2004;10(23):2861-89. Review.

PMID:
15379674
7.

PACAP in avians: origin, occurrence, and receptors--pharmacological and functional considerations.

Nowak JZ, Zawilska JB.

Curr Pharm Des. 2003;9(6):467-81. Review.

PMID:
12570810
8.

Growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in the reproductive system.

Moretti C, Mencacci C, Frajese GV, Cerilli M, Frajese G.

Trends Endocrinol Metab. 2002 Dec;13(10):428-35. Review.

PMID:
12431839
9.

PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways.

Zhou CJ, Shioda S, Yada T, Inagaki N, Pleasure SJ, Kikuyama S.

Curr Protein Pept Sci. 2002 Aug;3(4):423-39. Review.

PMID:
12370005
10.

Pituitary adenylate cyclase-activating polypeptide and its receptors in amphibians.

Yon L, Alexandre D, Montéro M, Chartrel N, Jeandel L, Vallarino M, Conlon JM, Kikuyama S, Fournier A, Gracia-Navarro F, Roubos E, Chow B, Arimura A, Anouar Y, Vaudry H.

Microsc Res Tech. 2001 Aug 1;54(3):137-57. Review.

PMID:
11458398
12.
13.

Gut/brain peptides in the genital tract: VIP and PACAP.

Fahrenkrug J.

Scand J Clin Lab Invest Suppl. 2001;234:35-9. Review.

PMID:
11713978
14.

Passage of VIP/PACAP/secretin family across the blood-brain barrier: therapeutic effects.

Dogrukol-Ak D, Tore F, Tuncel N.

Curr Pharm Des. 2004;10(12):1325-40. Review.

PMID:
15134484
15.

[Pituitary adenylate cyclase activating peptide (PACAP)--its polyfunctionality in the mechanisms of brain protection].

Chepurnov SA, Chepurnova NE, Ponomarenko AA, Pereverzev MO.

Usp Fiziol Nauk. 1999 Apr-Jun;30(2):3-20. Review. Russian.

PMID:
10420472
16.

[The role of the novel hypothalamic peptide PACAP in regulating endocrine functions].

Grinevich VV.

Usp Fiziol Nauk. 1997 Jan-Mar;28(1):47-52. Review. Russian.

PMID:
9139476
18.

Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.

Tachibana T, Saito ES, Takahashi H, Saito S, Tomonaga S, Boswell T, Furuse M.

Regul Pept. 2004 Aug 15;120(1-3):99-105.

PMID:
15177926
19.

Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.

Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ.

J Mol Neurosci. 2005;25(3):215-24.

PMID:
15800375
20.

Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.

Dejda A, Sokołowska P, Nowak JZ.

Pharmacol Rep. 2005 May-Jun;57(3):307-20. Review.

Supplemental Content

Support Center